Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
BlackBerry
BB
$4.57B
| $12.4M | 0.01% |
1,557,620
-723,683
| -32% | -$5.44M |
|
|
MJN
1352
CALL
DELISTED
Mead Johnson Nutrition Company
MJN
| $12.4M | 0.01% |
157,300
-78,400
| -33% | -$6.69M |
|
|
NBL
1353
PUT
DELISTED
Noble Energy, Inc.
NBL
| $12.4M | 0.01% |
347,600
+165,800
| +91% | +$5.82M |
|
1354
SLB Ltd
SLB
$79.1B
| $12.4M | 0.01% |
157,686
-21,580
| -12% | -$1.71M |
|
1355
PUT
Cemex
CX
$15.9B
| $12.4M | 0.01% |
1,623,802
+256,352
| +19% | +$1.89M |
|
|
AIRM
1356
PUT
DELISTED
Air Methods Corp
AIRM
| $12.4M | 0.01% |
393,100
+254,500
| +184% | +$8.67M |
|
|
FISV
1357
CALL
Fiserv Inc
FISV
$27.9B
| $12.4M | 0.01% |
248,800
+125,800
| +102% | +$6.6M |
|
1358
CALL
Intuit
INTU
$97.8B
| $12.3M | 0.01% |
112,200
-27,800
| -20% | -$3.11M |
|
1359
PUT
SolarEdge
SEDG
$1.84B
| $12.3M | 0.01% |
715,800
+455,500
| +175% | +$8.03M |
|
1360
Western Digital
WDC
$163B
| $12.3M | 0.01% |
277,479
-842,958
| -75% | -$31.8M |
|
1361
Jazz Pharmaceuticals
JAZZ
$16.9B
| $12.3M | 0.01% |
100,919
+856
| +0.9% | +$115K |
|
|
ZAYO
1362
CALL
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $12.3M | 0.01% |
412,500
+186,500
| +83% | +$5.39M |
|
1363
PUT
Nu Skin
NUS
$236M
| $12.2M | 0.01% |
189,000
+26,800
| +17% | +$1.51M |
|
1364
CALL
Olin
OLN
$1.98B
| $12.2M | 0.01% |
593,500
-377,500
| -39% | -$8.12M |
|
1365
PUT
Nokia
NOK
$57.8B
| $12.2M | 0.01% |
2,100,200
-1,219,300
| -37% | -$6.93M |
|
1366
CALL
Tenet Healthcare
THC
$21.9B
| $12.1M | 0.01% |
533,700
-82,900
| -13% | -$2.16M |
|
1367
Advance Auto Parts
AAP
$2.63B
| $12.1M | 0.01% |
81,048
+79,348
| +4,668% | +$12.7M |
|
1368
PUT
iShares Core S&P 500 ETF
IVV
$894B
| $12.1M | 0.01% |
55,400
+19,000
| +52% | +$4.13M |
|
1369
CALL
Ubiquiti
UI
$34.9B
| $12M | 0.01% |
224,900
+50,400
| +29% | +$2.42M |
|
|
AVP
1370
CALL
DELISTED
Avon Products, Inc.
AVP
| $12M | 0.01% |
2,123,500
-56,100
| -3% | -$280K |
|
1371
PUT
Diageo
DEO
$52.7B
| $12M | 0.01% |
103,300
-253,900
| -71% | -$29M |
|
|
GWPH
1372
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $12M | 0.01% |
+90,108
| New | +$8.61M |
|
|
SIVB
1373
PUT
DELISTED
SVB Financial Group
SIVB
| $11.9M | 0.01% |
108,100
-176,800
| -62% | -$18.4M |
|
|
AXON
1374
PUT
Axon Enterprise
AXON
$49.8B
| $11.9M | 0.01% |
416,900
+40,400
| +11% | +$1.12M |
|
1375
PUT
United Therapeutics
UTHR
$22.2B
| $11.9M | 0.01% |
101,000
-18,100
| -15% | -$2.17M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.